Samsara Bio Capital, LLC Io Biotech, Inc. Transaction History
Samsara Bio Capital, LLC
- $317 Million
- Q1 2024
A detailed history of Samsara Bio Capital, LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 3,640,015 shares of IOBT stock, worth $4.26 Million. This represents 1.99% of its overall portfolio holdings.
Number of Shares
3,640,015
Previous 3,640,015
-0.0%
Holding current value
$4.26 Million
Previous $6.84 Million
7.98%
% of portfolio
1.99%
Previous 2.22%
Shares
4 transactions
Others Institutions Holding IOBT
# of Institutions
18Shares Held
27MCall Options Held
988KPut Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$7.22 Million1.43% of portfolio
-
Novo Holdings Hellerup, G75.09MShares$5.95 Million0.71% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$2.74 Million0.2% of portfolio
-
Morgan Stanley New York, NY2.2MShares$2.57 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$2.46 Million0.01% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $33.7M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...